Table 3. Selected substances and signals differing between the WHO classes (healthy, diabetes) at visits V1 and V2.
| Median concentration (IQR) [mM/mM Creatinine] | t-test | |||
| Visita | Compound | WHO: healthy | WHO: GDM | p-value |
| V1 | Citrate | 0.23 (0.18–0.29) | 0.28 (0.19–0.34) | 2e-4 (↑) |
| Unknown doublet, 1.08 ppmx | 3.4 (2.2–4.8) | 4 (2.5–6.4) | 0.007 (↑) | |
| Unknown doublet, 1.11 ppmx | 11 (7.5–15) | 14 (8.9–18) | 9e-4 (↑) | |
| V2 | Citrate | 0.24 (0.17–0.31) | 0.3 (0.22–0.4) | 7e-5 (↑) |
| Unknown doublet, 1.08 ppmx | 5.4 (3.5–7.9) | 5.6 (4.2–10) | 0.01 (↑) | |
| Unknown doublet, 1.11 ppmx | 19 (14–25) | 24 (17–29) | 0.001 (↑) | |
a
Visit V1: gestational week 8–20; V2: gestational week 26–30.
x
Concentrations of unidentified signals in arbitrary units, but nonetheless normalized to creatinine.